These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26306761)

  • 1. Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow.
    Uitterdijk A; Yetgin T; te Lintel Hekkert M; Sneep S; Krabbendam-Peters I; van Beusekom HM; Fischer TM; Cornelussen RN; Manintveld OC; Merkus D; Duncker DJ
    Basic Res Cardiol; 2015 Sep; 110(5):508. PubMed ID: 26306761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-amplitude, left vagus nerve stimulation significantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury.
    Shinlapawittayatorn K; Chinda K; Palee S; Surinkaew S; Thunsiri K; Weerateerangkul P; Chattipakorn S; KenKnight BH; Chattipakorn N
    Heart Rhythm; 2013 Nov; 10(11):1700-7. PubMed ID: 23933295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers.
    Nuntaphum W; Pongkan W; Wongjaikam S; Thummasorn S; Tanajak P; Khamseekaew J; Intachai K; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
    Basic Res Cardiol; 2018 May; 113(4):22. PubMed ID: 29744667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction.
    Shinlapawittayatorn K; Chinda K; Palee S; Surinkaew S; Kumfu S; Kumphune S; Chattipakorn S; KenKnight BH; Chattipakorn N
    Heart Rhythm; 2014 Dec; 11(12):2278-87. PubMed ID: 25093803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Level Vagus Nerve Stimulation Attenuates Myocardial Ischemic Reperfusion Injury by Antioxidative Stress and Antiapoptosis Reactions in Canines.
    Chen M; Zhou X; Yu L; Liu Q; Sheng X; Wang Z; Wang S; Jiang H; Zhou S
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):224-31. PubMed ID: 26546374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous electrical vagal nerve stimulation prior to coronary reperfusion in a canine ischemia-reperfusion model markedly reduces infarct size and prevents subsequent heart failure.
    Arimura T; Saku K; Kakino T; Nishikawa T; Tohyama T; Sakamoto T; Sakamoto K; Kishi T; Ide T; Sunagawa K
    Int J Cardiol; 2017 Jan; 227():704-710. PubMed ID: 27816306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion.
    Zhao M; He X; Bi XY; Yu XJ; Gil Wier W; Zang WJ
    Basic Res Cardiol; 2013 May; 108(3):345. PubMed ID: 23519622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase.
    Kiss A; Tratsiakovich Y; Mahdi A; Yang J; Gonon AT; Podesser BK; Pernow J
    Acta Physiol (Oxf); 2017 Nov; 221(3):174-181. PubMed ID: 28238218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beneficial effects of adenosine on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):453-8. PubMed ID: 15932708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
    Dai W; Hale S; Kloner RA
    Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beneficial effects of fosinopril on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):638-42. PubMed ID: 16080815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
    Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
    Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction.
    Kapur NK; Qiao X; Paruchuri V; Morine KJ; Syed W; Dow S; Shah N; Pandian N; Karas RH
    JACC Heart Fail; 2015 Nov; 3(11):873-82. PubMed ID: 26541785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
    Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
    Reffelmann T; Hale SL; Li G; Kloner RA
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord stimulation effects on myocardial ischemia, infarct size, ventricular arrhythmia, and noninvasive electrophysiology in a porcine ischemia-reperfusion model.
    Odenstedt J; Linderoth B; Bergfeldt L; Ekre O; Grip L; Mannheimer C; Andréll P
    Heart Rhythm; 2011 Jun; 8(6):892-8. PubMed ID: 21255678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beneficial effects of ischemic preconditioning on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):486-90. PubMed ID: 16178445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.